Your browser doesn't support javascript.
loading
Clinical and molecular correlates of JAK-inhibitor therapy failure in myelofibrosis: long-term data from a molecularly annotated cohort.
England, James T; McNamara, Caroline J; Kennedy, James A; Capo-Chichi, Jose-Mario; Huang, Jingyue; Arruda, Andrea; Nye, Taylor; Cheung, Verna; Claudio, Jaime O; Maze, Dawn; Sibai, Hassan; Tierens, Anne; Tsui, Hubert; Bankar, Aniket; Xu, Wei; Stockley, Tracy; Gupta, Vikas.
Afiliação
  • England JT; Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • McNamara CJ; Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Kennedy JA; Medical Oncology and Hematology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Capo-Chichi JM; Division of Clinical Laboratory Genetics, Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
  • Huang J; Biostatistics, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Arruda A; Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Nye T; Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Cheung V; Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Claudio JO; Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Maze D; Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Sibai H; Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Tierens A; Laboratory Hematology, Toronto General Hospital, Toronto, Ontario, Canada.
  • Tsui H; Laboratory Hematology, Toronto General Hospital, Toronto, Ontario, Canada.
  • Bankar A; Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Xu W; Biostatistics, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Stockley T; Division of Clinical Laboratory Genetics, Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
  • Gupta V; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Leukemia ; 36(6): 1689-1692, 2022 06.
Article em En | MEDLINE | ID: mdl-35347238

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mielofibrose Primária / Inibidores de Janus Quinases Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mielofibrose Primária / Inibidores de Janus Quinases Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá País de publicação: Reino Unido